Healthcare and medtech companies need marketing leadership that understands regulatory complexity, clinical evidence requirements, and reimbursement challenges. You can't afford to wait until FDA approval to build go-to-market strategy.

The Healthcare & MedTech Marketing Problem

FDA timelines create unpredictable launches

FDA approval timelines create unpredictable go-to-market windows for medical devices, making it difficult to build marketing teams, plan campaigns, and coordinate with sales operations.

Clinical evidence requirements exceed startup capabilities

Healthcare provider sales require clinical evidence and outcomes data that most medtech startups lack the resources or expertise to develop and communicate effectively.

Reimbursement complexity affects customer acquisition

Insurance reimbursement complexity affects pricing strategy and customer acquisition, but most marketing teams don't understand how reimbursement policies influence buying decisions.

How We Navigate Healthcare & MedTech Marketing

We build healthcare and medtech marketing strategies that work within regulatory constraints while maximizing commercial opportunities.

Our approach starts with regulatory-aligned go-to-market planning. We create launch strategies that optimize timing around FDA milestones, build awareness before approval, and execute rapid market entry when regulatory clearance arrives.

We integrate clinical evidence into commercial strategy by working with your clinical and regulatory teams to translate study results into compelling marketing messages. This includes developing evidence-based value propositions that resonate with healthcare providers and payers.

For reimbursement optimization, we build business models and pricing strategies that account for insurance coverage patterns, prior authorization requirements, and payer decision-making processes.

Our healthcare marketing strategies include compliance frameworks that ensure all marketing activities meet FDA, FTC, and industry advertising requirements while maximizing commercial impact.

Our approach starts with a thorough assessment of your current growth infrastructure. We review what is working, what is not, and where the highest-impact opportunities are. This diagnostic phase ensures we are solving the right problems before committing resources to execution.

What makes our approach different: embedded leadership model — not external consulting, operator mentality — we own the number, not just the strategy, 90-day sprint approach with clear phase gates. We operate as an extension of your team, not as outside advisors delivering slide decks. The fractional model means you get senior expertise without the overhead of a full-time hire, and the 90-day sprint structure ensures you see measurable progress at every phase.

We build measurement into every engagement from day one. Before we change anything, we establish baseline metrics so progress is tracked against real numbers. Monthly reporting shows what is working, what needs adjustment, and where to invest next. No vanity metrics — only indicators that connect to revenue.

What we deliver

Regulatory-aligned go-to-market strategy optimized for FDA approval timelines
Clinical evidence integration that translates studies into compelling provider messaging
Reimbursement-optimized business model that ensures sustainable customer acquisition

Healthcare and medtech companies need marketing leadership that understands regulatory complexity, clinical evidence requirements, and reimbursement challenges.

Our Methodology

Our methodology starts with a 90-day sprint designed to create immediate impact while building long-term systems. In the first 30 days, we embed with your leadership team to audit existing marketing infrastructure, review performance data, identify quick wins, and understand the competitive landscape specific to your vertical. We interview key stakeholders, review your analytics stack, and map the customer journey from first touch to closed deal.

Days 30-60 focus on strategy development and early execution. We build a prioritized growth roadmap, restructure team roles where needed, and start implementing the highest-impact changes. This phase includes establishing measurement frameworks so we can track progress against real metrics, not vanity numbers.

Days 60-90 shift to full execution mode. Systems are running, the team is aligned, and we're optimizing based on real data. By the end of the sprint, you have a functioning growth engine with clear ownership and accountability — something that works whether we stay on or not.

How We Work

In the first 30 days, we conduct a full marketing and growth audit. This includes reviewing your analytics stack, interviewing key stakeholders, mapping the customer journey, and identifying the three to five highest-impact opportunities. We establish baseline metrics so we can measure progress against real targets.

During days 30-60, we move into strategy development and early execution. We build a prioritized growth roadmap, begin restructuring team roles where needed, and start implementing quick wins identified in the audit phase. Weekly check-ins keep the team aligned and the leadership team informed.

Days 60-90 are full execution mode. Systems are running, the team knows their roles, and we're optimizing based on real performance data. We provide monthly strategy presentations to the leadership team covering what's working, what's not, and what we're changing.

Most engagements run 3-6 months initially. We work 15-25 hours per week embedded with your team — attending leadership meetings, managing agency relationships, and making resource allocation decisions. The goal is to build systems that outlast the engagement.

Regulatory compliance assurance
Clinical evidence commercialization
Reimbursement strategy optimization

If your healthcare & medtech company needs fractional cxo leadership, we should talk.

Expand your marketing team output with our experts

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.

Frequently asked questions

fractional cmo for healthcare companies

We specialize in healthcare and medtech marketing challenges including FDA regulatory alignment, clinical evidence commercialization, and reimbursement strategy optimization. Our experience spans medical devices, digital health, and healthcare services companies.

medtech startup marketing consultant

As a medtech startup marketing consultant, we understand the unique challenges of launching medical devices including regulatory timelines, clinical evidence requirements, and healthcare provider sales cycles. We build marketing strategies that work within these constraints.

healthcare marketing strategy

Healthcare marketing strategy requires understanding regulatory compliance, clinical evidence communication, and reimbursement complexity. We create marketing frameworks that navigate these requirements while building sustainable commercial growth.

How much does a fractional CXO engagement cost?

Fractional CXO engagements typically run $15K-$25K per month depending on scope, company stage, and time commitment. Compare that to a full-time CMO or CGO hire at $250K-$400K base salary plus equity, benefits, and hiring risk. You get senior operator-level expertise at a fraction of the cost, with the flexibility to scale engagement scope as your needs evolve.

How long before we see results from a fractional CXO?

Initial diagnostic insights and quick wins typically surface within the first 30 days. Structural improvements — team alignment, measurement frameworks, channel optimization — show measurable impact by day 60-90. Compounding growth effects from systematic changes become clear at the 3-6 month mark. The 90-day sprint is designed to deliver value at every phase, not just at the end.

How does the fractional model work day-to-day?

We work 15-25 hours per week embedded with your team. That includes attending leadership meetings, managing agency relationships, making resource allocation decisions, and building growth systems. Weekly execution check-ins keep the team aligned. Monthly strategy presentations give leadership visibility into progress and priorities. We operate as a member of your team, not an outside consultant.